Prospective data and sample collection

OTHER2 trials

Sponsors

Universitaire Ziekenhuizen KU Leuven, Jules Bordet Institute

Conditions

Breast NeoplasmsEarly-stage Breast CancerEstrogen-receptor-positive Breast Cancer

Phase 2

Ketorolac and Pregabalin Effects on breaSt Cancer (KePreSt)

RecruitingNCT06150898

Jules Bordet InstituteEarly-stage Breast Cancer, Estrogen-receptor-positive Breast Cancer

Start: 2025-05-12End: 2027-10-31Target: 112Updated: 2025-06-13

Unknown Phase

FATLAS: Comprehensive Multi-level Characterization of Systemic and Mammary Adiposity in Breast Cancer Patients.

RecruitingNCT04200768

Universitaire Ziekenhuizen KU LeuvenBreast Neoplasms

Start: 2020-09-01End: 2024-10-31Target: 150Updated: 2024-06-28